Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting: An Economic Markov Model Evaluation

被引：6
|
作者：
Kovacs, Norbert [1 ]
Janszky, Jozsef [1 ]
Nagy, Ferenc [1 ,2 ]
机构：
[1] Univ Pecs, Dept Neurol, Pecs, Hungary
[2] Kaposi Mor Cty Hosp, Dept Neurol, Kaposvar, Hungary
来源：
DRUGS & AGING | 2011年 / 28卷 / 02期
关键词：
RANDOMIZED CONTROLLED-TRIAL; INITIAL TREATMENT; LEVODOPA;
D O I：
10.2165/80-000000000-00000
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：161 / 162
页数：2
相关论文
共 50 条
  • [1] Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting An Economic Markov Model Evaluation
    Haycox, Alan
    Armand, Christophe
    Murteira, Susana
    Cochran, John
    Francois, Clement
    DRUGS & AGING, 2009, 26 (09) : 791 - 801
  • [2] Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson’s Disease in the UK SettingAn Economic Markov Model Evaluation
    Alan Haycox
    Christophe Armand
    Susana Murteira
    John Cochran
    Clément François
    Drugs & Aging, 2009, 26 : 791 - 801
  • [3] Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson’s Disease in the UK SettingAn Economic Markov Model Evaluation
    Norbert Kovacs
    Jozsef Janszky
    Ferenc Nagy
    Drugs & Aging, 2011, 28 : 161 - 162
  • [4] COST EFFECTIVENESS OF RASAGILINE AND PRAMIPEXOL IN EARLY PARKINSON'S DISEASE IN THE MEXICAN SETTING
    Pizarro, M.
    Rizzoli, A.
    Salmeron, G.
    Gonzalez, N.
    Soto, H.
    VALUE IN HEALTH, 2012, 15 (04) : A144 - A144
  • [5] Cost-effectiveness analysis of pramipexole in early Parkinson's disease
    Noyes, K
    Dick, AW
    Holloway, RG
    VALUE IN HEALTH, 2003, 6 (03) : 274 - 274
  • [6] Cost effectiveness of pramipexole in Parkinson's disease in the US
    Hoerger, TJ
    Bala, MV
    Rowland, C
    Greer, M
    Chrischilles, EA
    Holloway, RG
    PHARMACOECONOMICS, 1998, 14 (05) : 541 - 557
  • [7] Pramipexole and levodopa in early Parkinson's disease - Dynamic changes in cost effectiveness
    Noyes, K
    Dick, AW
    Holloway, RG
    PHARMACOECONOMICS, 2005, 23 (12) : 1257 - 1270
  • [8] Cost Effectiveness of Pramipexole in Parkinson’s Disease in the US
    Thomas J. Hoerger
    Mohan V. Bala
    Clayton Rowland
    Marianne Greer
    Elizabeth A. Chrischilles
    Robert G. Holloway
    PharmacoEconomics, 1998, 14 : 541 - 557
  • [9] Pramipexole for the treatment of early Parkinson's disease
    Perez-Lloret, Santiago
    Rey, Maria Veronica
    Ratti, Luca
    Rascol, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (07) : 925 - 935
  • [10] Cost-effectiveness of pramipexole compared with piribedil in early Parkinson's disease patients
    Chikina, ES
    Gusev, EL
    Belousov, YB
    Guecht, AB
    VALUE IN HEALTH, 2005, 8 (03) : 321 - 321
12345